Dr. Rainer Boger Scientific Validation:
Dr. Rainer Boger received his medical training at Hannover Medical School in Hannover, Germany. He received his postgraduate training in Internal Medicine and Pharmacology both in Hannover and at Stanford University School of Medicine in Stanford, CA. He is currently the Professor of Clinical Pharmacology and Director of the Institute of Clinical Pharmacology and Toxicology at Hamburg University Medical Center, Germany. He is also Director of the Clinical Trial Center North at Hamburg University.
Dr. Bogers scientific work centers on the early diagnosis and prevention of cardiovascular-related diseases. He has dedicated more than two decades of academic research related to L-arginine and its influence on the bodys ability to produce nitric oxide. His major achievements are the discovery that ADMA (asymmetric dimethylarginine) is a risk marker of vascular disease and the utilization of L-arginine to prevent vascular dysfunction and disease. Dr. Boger regularly collaborates with renowned institutions like the Mayo Clinic and Stanford University Medical Center and has documented his knowledge in more than 200 scientific articles, of which 130 exclusively cover the roles of ADMA and L-arginine in cardiovascular and metabolic diseases.
Böger RH. J.Nutr. 2007_137_1650S-1655S
Schwedhelm E, et al. Br J Clin Pharmacol. 2008_65_51-9
Schutte AE, et al. Eur J Endocrinol. 2010_162_525-33
Böger RH, et.al. Circulation 1998_98_1842-1847 (1)
Kielstein JT, et.al. J.Am.Soc.Nephrol. 1999_10_594-600
Chan JR, et.al. Arterioscler.Thromb.Vasc.Biol. 2000_20_1040-1046
Böger RH, et.al. Circ.Res. 2000_87_99-105
Kielstein JT, et.al. J.Am.Soc.Nephrol. 2002_13_170-176
Böger RH. Cardivasc.Res. 2003_59_824-833
Böger RH. J.Nutr. 2004_134_ 2842S-2847S
Krempl TK, et.al. Eur.HeartJ. 2005_26_1846-1851
Böger RH. Crit Care. 2006_10_169
Jacobi J, et.al. Am J Physiol Heart Circ Physiol 2008_294_1058-1066
